CSS »

Ascendis Pharma A/s shares owned by CSS

Quarter-by-quarter ownership of Ascendis Pharma A/s shares owned by CSS from 13F filings

Historical chart of CSS investment in Ascendis Pharma A/s

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A/s held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A/s by CSS

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 13M 1.03

More positions owned by CSS

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Noble Corp Ord Shs A (NE)
Ark Etf Tr Innovation Etf Call Option (ARKK)
American Airlines Group Note 6.500% 7/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Mirati Therapeutics
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Splunk Note 1.125% 9/1 (Principal)
American Airls Put Option (AAL)
Ncl Corp Note 5.375% 8/0 (Principal)
Marriott Vacations Worldwide Note 1/1 (Principal)
Brookdale Sr Living Unit 11/15/2025 (BKDT)

View all positions for CSS

Top funds holding Ascendis Pharma A/s

Wolverine Asset Management
Braidwell
Franklin Resources
Aviva
Readystate Asset Management
D. E. Shaw & Co
Point72 Asset Management
Zazove Associates
CSS
Jane Street
Calamos Advisors
Capstone Investment Advisors
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
SSI Investment Management
DAFNA Capital Management

View all funds holding Ascendis Pharma A/s